Literature DB >> 8232274

Distribution and regulation of natriuretic factor-R1C receptor subtypes in mammalian cell lines.

J Féthière1, R Graihle, L Larose, K Babinski, H Ong, A De Léan.   

Abstract

The differential distribution of natriuretic peptide receptor subtypes and their distinct properties were assessed in mammalian cellular models which were screened for their ability to produce cGMP upon stimulation by different natriuretic peptides. The ANF-R1A receptor subtype was distinguished by its selective activation by atrial natriuretic factor (ANF) while the ANF-R1C was characterized by preferential stimulation by C-type natriuretic peptide (CNP). AT-620 pituitary cells, bovine adrenal chromaffin cells, and NIH-3T3 fibroblasts mainly express the ANF-R1C receptor subtype. Other cell lines such as PC12, RASM and GH3 express significant but varying amounts of both ANF-R1A and ANF-R1C subtypes. A10 and NIH cells which express high density of ANF-R2 receptor subtype, also demonstrate a higher sensitivity to CNP over ANF suggesting that they express significant amounts of ANF-R1C. Studies of the regulation by ATP of guanylyl cyclase activity indicate that both ANF-R1A and ANF-R1C subtypes are modulated in the same manner. In the presence of Mn2+, ATP inhibits the CNP-stimulated guanylyl cyclase activity while in the presence of Mg2+ adenine nucleotides potentiate the stimulation by CNP. In addition, we show that like the ANF-R1A, the ANF-R1C guanylyl cyclase activity can be regulated by phosphorylation since preincubation with TPA or FKL attenuates the subsequent stimulation by CNP in cultured cells. The results presented demonstrate that specific cell types express distinct natriuretic peptide receptor subtypes and also that the newly characterized ANF-R1C subtype is regulated by ATP and serine/threonine kinases in the same way as the ANF-R1A subtype.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8232274     DOI: 10.1007/bf01096376

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  24 in total

1.  Physiological role of silent receptors of atrial natriuretic factor.

Authors:  T Maack; M Suzuki; F A Almeida; D Nussenzveig; R M Scarborough; G A McEnroe; J A Lewicki
Journal:  Science       Date:  1987-10-30       Impact factor: 47.728

2.  Distinct properties of atrial natriuretic factor receptor subpopulations in epithelial and fibroblast cell lines.

Authors:  J Féthière; S Meloche; T T Nguyen; H Ong; A De Lean
Journal:  Mol Pharmacol       Date:  1989-05       Impact factor: 4.436

3.  Secretion and biosynthesis of atrial natriuretic factor by cultured adrenal chromaffin cells.

Authors:  T T Nguyen; H Ong; A De Léan
Journal:  FEBS Lett       Date:  1988-04-25       Impact factor: 4.124

4.  Pharmacological evidence for the heterogeneity of atrial natriuretic factor-R1 receptor subtype.

Authors:  J Féthière; A De Léan
Journal:  Mol Pharmacol       Date:  1991-12       Impact factor: 4.436

5.  A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor.

Authors:  M Chinkers; D L Garbers; M S Chang; D G Lowe; H M Chin; D V Goeddel; S Schulz
Journal:  Nature       Date:  1989-03-02       Impact factor: 49.962

6.  Participation of adenosine 5'-triphosphate in the activation of membrane-bound guanylate cyclase by the atrial natriuretic factor.

Authors:  H Kurose; T Inagami; M Ui
Journal:  FEBS Lett       Date:  1987-07-27       Impact factor: 4.124

7.  Modulation of atrial natriuretic peptide-induced cGMP accumulation by [Arg8]vasopressin in the cultured renal epithelial cell line, LLC-PK1.

Authors:  D Neuser; J P Stasch; F J Morich
Journal:  Eur J Pharmacol       Date:  1988-02-09       Impact factor: 4.432

8.  Characterization of high affinity receptor sites for atrial natriuretic factor in anterior pituitary gland: evidence for the existence of two receptor forms.

Authors:  B Koch; T Boudjada; B Lutz-Bucher
Journal:  Biochem Biophys Res Commun       Date:  1988-04-29       Impact factor: 3.575

9.  Vasopressin-mediated inhibition of atrial natriuretic factor-stimulated cGMP accumulation in an established smooth muscle cell line.

Authors:  P Nambi; M Whitman; G Gessner; N Aiyar; S T Crooke
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

10.  Human atrial natriuretic peptide receptor defines a new paradigm for second messenger signal transduction.

Authors:  D G Lowe; M S Chang; R Hellmiss; E Chen; S Singh; D L Garbers; D V Goeddel
Journal:  EMBO J       Date:  1989-05       Impact factor: 11.598

View more
  4 in total

1.  Regulation of ANP-stimulated guanylate cyclase in the presence of Mn2+ in rat lung membranes.

Authors:  T Nashida; A Imai; H Shimomura
Journal:  Mol Cell Biochem       Date:  2000-05       Impact factor: 3.396

2.  Distinct inhibitory ATP-regulated modulatory domain (ARMi) in membrane guanylate cyclases.

Authors:  T Duda; R Goraczniak; R K Sharma
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

3.  Characterization of the phosphorylation state of natriuretic peptide receptor-C.

Authors:  L Pedro; R Fenrick; M Marquis; N McNicoll; A De Léan
Journal:  Mol Cell Biochem       Date:  1998-01       Impact factor: 3.396

4.  Cloning and functional expression of the bovine natriuretic peptide receptor-B (natriuretic factor R1c subtype.

Authors:  R Fenrick; K Babinski; N McNicoll; M Therrien; J Drouin; A De Léan
Journal:  Mol Cell Biochem       Date:  1994-08-31       Impact factor: 3.396

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.